Home
>
National Drug Code (NDC)
>
Acyclovir
Acyclovir - 10544-101-25 - (Acyclovir)
Drug Information of Acyclovir
| Product NDC: | 10544-101 |
| Proprietary Name: | Acyclovir |
| Non Proprietary Name: | Acyclovir |
| Active Ingredient(s): | 200 mg/1 & nbsp; Acyclovir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Acyclovir
| Product NDC: | 10544-101 |
| Labeler Name: | Blenheim Pharmacal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074578 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110215 |
Package Information of Acyclovir
| Package NDC: | 10544-101-25 |
| Package Description: | 25 CAPSULE in 1 BOTTLE (10544-101-25) |
NDC Information of Acyclovir
| NDC Code | 10544-101-25 |
| Proprietary Name | Acyclovir |
| Package Description | 25 CAPSULE in 1 BOTTLE (10544-101-25) |
| Product NDC | 10544-101 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acyclovir |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110215 |
| Marketing Category Name | ANDA |
| Labeler Name | Blenheim Pharmacal, Inc. |
| Substance Name | ACYCLOVIR |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
